Suchergebnisse - (Person:"Wu, Jiajing")

PubPharm (7)

1

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

enthalten in: Emerging microbes & infections | 2023

von Liang, Z. | Wu, X. | Wu, J. | +11

2

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

enthalten in: Signal transduction and targeted therapy | 2022

von Li, Q. | Zhang, L. | Liang, Z. | +13

3

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

enthalten in: Nature | 2022

von Wang, K. | Jia, Z. | Bao, L. | +31

CommentIn: Signal Transduct Target Ther. 2022 Apr 5;7(1):115. - PMID 35383164

4

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain

enthalten in: Signal transduction and targeted therapy | 2022

von Wu, J. | Nie, J. | Zhang, L. | +16

5

Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19

enthalten in: Vaccine | 2021

von Zhou, Z. | Zhang, X. | Li, Q. | +14

6

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom

enthalten in: Frontiers in immunology | 2021

von Wu, J. | Zhang, L. | Zhang, Y. | +11

7

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

enthalten in: Emerging microbes & infections | 2020

von Nie, J. | Li, Q. | Wu, J. | +15

1
[1]